课题基金 / 基金详情

SOMATIC CELL GENETICS OF T-CELL DIFFERENTIATION ANTIGENS

SOMATIC CELL GENETICS OF T-CELL DIFFERENTIATION ANTIGENS
T 细胞分化抗原的体细胞遗传学
批准号:
3171055
负责人:
ROSS S BASCH
金额:
$9.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-07-01 至 1989-12-31

项目摘要

项目成果

ROSS S BASCH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We shall use somatic cell genetic techniques to analyze the role of Lyt2 (T8), L3T4 (T4) and Ly5 (T200) in the function and differentiation of cells of the T lineage. We have developed methods of producing somatic variants of cloned normal and transformed cells, and we propose to use these techniques to select cell lines of "normal" T cells or T-cell precursors which either lack or express an altered form of a surface marker which normally serves as a differentiation antigen or cell lineage marker. We shall also produce cell lines which egregiously express markers normally present in other cells of the lineage or are derived from other species. We shall clone these cells, grow them in mass culture and study their antigenic structure, genetic organization, biological behavior and functional properties, comparing them with both their parent line and with immunoselected revertants. Specifically, we plan to prepare variants of a cultured prothymocyte line which prematurely express Lyt2 (or OKT8) and L3T4 (or OKT4) and study their subsequent differentiation. We will also prepare variants of helper T cell lines which either lack L3T4, or express either the human equivalent antigen (OKT4) or express the antigen associated with the suppressor phenotype (OKT8).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
C21, a Transcriptional Regulator in Hematopoiesis
C21, a Transcriptional Regulator in Hematopoiesis
C21, a Transcriptional Regulator in Hematopoiesis
C21, a Transcriptional Regulator in Hematopoiesis
海外基金